Available data, however, support a model in which loss-of-function SMAD6 variants are likely to result in variable phenotypes depending on concomitant genetic or environmental factors, as proved by the recurrence of the same variants in patients affected with either BAV/TAA or craniosynostosis [17,20]. This evidence concerns the gene SMAD6 and craniosynostosis.